First-trimester maternal serum PP13 in the risk assessment for preeclampsia

This publication has 102 references indexed in Scilit:

• Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor
  American Journal of Obstetrics and Gynecology, 2007
• Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction
  The Journal of Experimental Medicine, 2006
• First Trimester Markers for Pre-Eclampsia: Placental vs. Non-Placental Protein Serum Levels
  Gynecologic and Obstetric Investigation, 2006
• Endogenous inhibitors of nitric oxide and preeclampsia: A review
  The Journal of Maternal-Fetal & Neonatal Medicine, 2006
• A role of the anti-angiogenic factor sVEGFR-1 in the ‘mirror syndrome’ (Ballantyne's syndrome)
  The Journal of Maternal-Fetal & Neonatal Medicine, 2006
• The Incidence of Severe Complications of Preeclampsia
  Hypertension in Pregnancy, 2005
• Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop
  American Journal of Obstetrics and Gynecology, 2004
• The role of uterine artery Doppler in predicting adverse pregnancy outcome
  Best Practice & Research Clinical Obstetrics & Gynaecology, 2004
• Pathophysiology of Preeclampsia: Linking Placental Ischemia/Hypoxia with Microvascular Dysfunction
  Microcirculation, 2002
• HELLP Syndrome
  Clinical Obstetrics and Gynecology, 1999